COMMUNIQUÉS West-GlobeNewswire

SteroTherapeutics Announces Closing of Financing to Accelerate Clinical Study for Non-Alcoholic Steatohepatitis (NASH)

27/02/2018 - 16:52

PHILADELPHIA, Feb. 27, 2018 (GLOBE NEWSWIRE) -- SteroTherapeutics, a privately held biopharmaceutical company developing metabolic-based therapies focused on non-alcoholic steatohepatitis (NASH), announced today the [...]

Canada’s nurses welcome reports of a federal pharmacare task force

27/02/2018 - 16:40

OTTAWA, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Canada’s nurses welcome recent media reports that the Hon. Eric Hoskins will lead a task force on national pharmacare. The Canadian Federation of Nurses Unions (CFNU) has been [...]

Novo Nordisk files for regulatory approval of long-acting factor VIII (N8-GP) in the US and the EU for treatment of haemophilia A

27/02/2018 - 16:10

Bagsværd, Denmark, 27 February 2018 - Novo Nordisk today announced the submission of a Biologics License Applications (BLA) to the US Food and Drug Administration (FDA) and a Marketing Authorisation Application (MAA) to [...]

Vizient, Inc. Awards National Contract to PDC Healthcare for Patient ID Bands

27/02/2018 - 16:00

VALENCIA, Calif., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Precision Dynamics Corporation (PDC Healthcare) , a global leader in healthcare identification and patient safety solutions, announced today that it has been awarded a [...]

Scapa Healthcare Unveils Three R&D Centers of Excellence in U.S. and Europe for Development of Innovative, Turn-key, Skin-Friendly Solutions

27/02/2018 - 16:00

WINDSOR, Conn., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Scapa Healthcare , a trusted strategic outsource partner of skin-friendly, turnkey solutions, unveiled its three R&D Centers of Excellence . Each Center offers full [...]

Intellia Therapeutics Announces Publication in Cell Reports of Preclinical Data Demonstrating Effective CRISPR/Cas9 Genome Editing Using Lipid Nanoparticle (LNP) Delivery Technology

27/02/2018 - 15:28

Intellia researchers achieved 97 percent reduction in serum transthyretin protein levels in mice through a single administration, with a durability of at least 12 months CRISPR/Cas9 administered via LNP was well- [...]

Voyager Therapeutics to Host Fourth Quarter and Full Year 2017 Financial Results and Corporate Highlights Conference Call

27/02/2018 - 15:17

CAMBRIDGE, Mass., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR ), a clinical-stage gene therapy company focused on developing treatments for severe neurological diseases, today announced [...]

PCI Synthesis Celebrates Key Milestones Including 4th Consecutive Year of Double-Digit Growth, 2 Commercial Approvals and a New Office in San Diego

27/02/2018 - 15:15

NEWBURYPORT, Mass., Feb. 27, 2018 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. ( www.pcisynthesis.com ), a pharmaceutical manufacturer of new chemical entities (NCEis), generic active pharmaceutical ingredients (APIs), and [...]

Aptevo Therapeutics to Present at the 30th Annual ROTH Conference

27/02/2018 - 15:02

SEATTLE, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq: APVO ), a biotechnology company focused on developing novel oncology and hematology therapeutics, today announced that management will be [...]

Sun Biopharma, Inc. Files United States Patent Protecting the Manufacturing Process for Its Lead Drug Candidate, SBP-101

27/02/2018 - 15:00

MINNEAPOLIS, MN, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (OTCQB:SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of pancreatic diseases, today [...]

OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2017 Financial Results on March 7, 2018

27/02/2018 - 15:00

WARSAW, Ind., Feb. 27, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS ), an orthopedic company focused exclusively on providing a comprehensive product offering to the pediatric orthopedic market, [...]

AXIM Biotech Announces First-Ever Successful Achievement of Proprietary cGMP Extraction and Manufacturing Methods for Pure Cannabinoid Molecules

27/02/2018 - 15:00

NEW YORK, Feb. 27, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies (OTC:AXIM) (“AXIM”), the world leader in cannabinoid research and development, today announced the first-ever successful execution of proprietary current [...]

Coherus BioSciences to Report Fourth Quarter and Full Year 2017 Financial Results on March 8th

27/02/2018 - 15:00

REDWOOD CITY, Calif., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS ), today announced that its fourth quarter and full year 2017 financial results will be released after market close on [...]

Data From SELLAS Life Sciences’ Positive Phase 2 Acute Myeloid Leukemia Study Published in American Society of Hematology’s Journal, Blood Advances

27/02/2018 - 14:45

NEW YORK, Feb. 27, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group Inc. (Nasdaq: SLS ) (SELLAS), a clinical-stage biopharmaceutical company focused on novel cancer immunotherapies for a broad range of cancer [...]

Transactions in relation to share buyback program

27/02/2018 - 14:33

Acting under its share buyback authorization, the GN Store Nord board of directors initiated a share buyback program on May 4, 2017 in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]

Precision Therapeutics Forms TumorGenesis Inc. Subsidiary to Focus on the Next Generation of Patient Derived Tumor Models

27/02/2018 - 14:30

MINNEAPOLIS, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT ) (“Precision” or “the Company”), formerly Skyline Medical (NASDAQ: SKLN ), a company focused on applying artificial intelligence [...]

BioCryst Reports Fourth Quarter and Full Year 2017 Financial Results

27/02/2018 - 14:30

Updates Investors Regarding Proposed Merger with Idera Pharmaceuticals, Inc. RESEARCH TRIANGLE PARK, N.C., Feb. 27, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ) announced today financial [...]

Hemispherx to Present at the Inaugural LD Micro Virtual Conference

27/02/2018 - 14:30

ORLANDO, Fla., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB), focused on pharmaceutical research, announced today that it will be presenting at the inaugural LD Micro Virtual [...]

Nuvectra to Present at Two Upcoming Investor Conferences

27/02/2018 - 14:30

PLANO, Texas, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR ), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief [...]